Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.600
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
3.624
+0.024 (0.66%)
After-hours: Jan 16, 2026, 7:41 PM EST
Q32 Bio Employees
As of December 31, 2024, Q32 Bio had 43 total employees, including 42 full-time and 1 part-time employees. The number of employees increased by 6 or 16.22% compared to the previous year.
Employees
43
Change (1Y)
6
Growth (1Y)
16.22%
Revenue / Employee
n/a
Profits / Employee
-$979,023
Market Cap
44.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43 | 6 | 16.22% |
| Dec 31, 2023 | 37 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QTTB News
- 6 weeks ago - Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
- 6 weeks ago - Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga
- 6 weeks ago - Q32 Bio Sells Complement Inhibitor ADX-097 - PRNewsWire
- 2 months ago - Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata - PRNewsWire
- 5 months ago - Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference - PRNewsWire
- 5 months ago - Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 7 months ago - Q32 Bio Appoints Adrien Sipos, M.D., Ph.D., as Interim Chief Medical Officer - PRNewsWire